Perrigo Company (PRGO)
-NasdaqGS 118.92 
1.06(0.90%) May 24, 4:00PM EDT|After Hours
:
118.92 0.00 (0.00%) May 24, 4:20PM EDT
| Prev Close: | 117.86 |
|---|
| Open: | 117.35 |
|---|
| Bid: | 116.16 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 126.57 |
|---|
| Beta: | 0.19 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 116.67 - 119.13 |
|---|
| 52wk Range: | 98.79 - 121.33 |
|---|
| Volume: | 403,796 |
|---|
| Avg Vol (3m): | 507,631 |
|---|
| Market Cap: | 11.18B |
|---|
| P/E (ttm): | 25.57 |
|---|
| EPS (ttm): | 4.65 |
|---|
| Div & Yield: | 0.36 (0.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Perrigo to transfer stock to NYSEAP(Thu, May 23)
- Perrigo to transfer common listing to NYSE from Nasdaqtheflyonthewall.com(Thu, May 23)
- InPlay: Perrigo to transfter common stock listing to NYSE from the NASDAQ Global Select MarketBriefing.com(Thu, May 23)
- Perrigo To Transfer Common Stock Listing To NYSEPR Newswire(Thu, May 23)
- PERRIGO CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; TransfEDGAR Online(Thu, May 23)
- 2 Healthcare Companies And 1 Consumer Goods Company With Recent Intensive Insider Sellingat Seeking Alpha(Mon, May 20)
- The New Generic-Drug Battle Frontat Motley Fool(Sat, May 18)
- Good News For Health Care Stocks Part 2at Motley Fool(Fri, May 17)
- PERRIGO CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Thu, May 16)
- Perrigo Stock Hits New 52-Week High (PRGO)at TheStreet(Wed, May 15)
- Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC MedicationsPR Newswire(Mon, May 13)
- These 4 Stocks Saw Trading Price Swings This Past Week Post Earningsat Wall St. Cheat Sheet(Sat, May 11)
- PERRIGO CO FinancialsEDGAR Online Financials(Sat, May 11)
- Perrigo Becomes #16 Most Shorted Nasdaq 100 Component, Replacing Intuitat TheStreet(Fri, May 10)
- Cramer Says Sell Teva Pharmaceutical, But Buy SunTrust Banks and These 2 Stocksat Wall St. Cheat Sheet(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | 17.99 |
|---|
| P/S (ttm): | 3.26 |
|---|
| Ex-Dividend Date: | 29-May-13 |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 5.62 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.57 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 1.78 |
|---|
Business Summary
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide.
View More